Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents
Clinical trial NCT01831505 · COMPLETED
Trial details
- NCT number
- NCT01831505
- Sponsor
- Presage Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.